Surgical and Advanced Medical Therapy for the Treatment of Type 2 Diabetes in Class I Obese Patients: a Short-Term Outcome

Surgical and Advanced Medical Therapy for the Treatment of Type 2 Diabetes in Class I Obese... Background Bariatric surgery, incretin-based therapy (gluca- dure to treat T2DM in class I obese patients. It is also superior gon-like peptide-1 analogues), and sodium-glucose co-trans- to advance medical treatment modalities such as GLP-1 ana- porter 2 (SGLT2) inhibitors have antidiabetic properties in logues and SGLT2 inhibitors. morbidly obese patients. However, their comparative efficacy . . in treating type 2 diabetes mellitus (T2DM) in class I obese Keywords Bariatric surgery Class I obesity GLP-1 patients specifically in Indian has not been studied yet. This analogues SGLT2 inhibitor study evaluates and compares the efficacy and side effect of surgical and advanced medical management of T2DM in class I obese patients. Introduction Methods T2DM patients with body mass index ranging from 30 to 35 kg/m and with a median duration of 3 years and Bariatric surgery has emerged as the preferred modality for HbA1c level >7.5% were recruited for the study. Selection of treatment of type 2 diabetes mellitus (T2DM) in morbidly treatment option that is bariatric surgery, GLP-1 analogues obese. Most patients are able to downgrade their medical man- and SGLT2 inhibitor, was kept on patient’schoice. Each agement with this modality and some can get rid of all med- group had http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Obesity Surgery Springer Journals

Surgical and Advanced Medical Therapy for the Treatment of Type 2 Diabetes in Class I Obese Patients: a Short-Term Outcome

Loading next page...
 
/lp/springer_journal/surgical-and-advanced-medical-therapy-for-the-treatment-of-type-2-kCkbSBVivZ
Publisher
Springer Journals
Copyright
Copyright © 2017 by Springer Science+Business Media, LLC
Subject
Medicine & Public Health; Surgery
ISSN
0960-8923
eISSN
1708-0428
D.O.I.
10.1007/s11695-017-2770-y
Publisher site
See Article on Publisher Site

Abstract

Background Bariatric surgery, incretin-based therapy (gluca- dure to treat T2DM in class I obese patients. It is also superior gon-like peptide-1 analogues), and sodium-glucose co-trans- to advance medical treatment modalities such as GLP-1 ana- porter 2 (SGLT2) inhibitors have antidiabetic properties in logues and SGLT2 inhibitors. morbidly obese patients. However, their comparative efficacy . . in treating type 2 diabetes mellitus (T2DM) in class I obese Keywords Bariatric surgery Class I obesity GLP-1 patients specifically in Indian has not been studied yet. This analogues SGLT2 inhibitor study evaluates and compares the efficacy and side effect of surgical and advanced medical management of T2DM in class I obese patients. Introduction Methods T2DM patients with body mass index ranging from 30 to 35 kg/m and with a median duration of 3 years and Bariatric surgery has emerged as the preferred modality for HbA1c level >7.5% were recruited for the study. Selection of treatment of type 2 diabetes mellitus (T2DM) in morbidly treatment option that is bariatric surgery, GLP-1 analogues obese. Most patients are able to downgrade their medical man- and SGLT2 inhibitor, was kept on patient’schoice. Each agement with this modality and some can get rid of all med- group had

Journal

Obesity SurgerySpringer Journals

Published: Jun 11, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off